Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Metabolism and Signal Transduction

Tissue-Specific Regulation of Mitochondrial and Cytoplasmic Protein Synthesis Rates by Insulin

  1. Yves Boirie,
  2. Kevin R. Short,
  3. Bo Ahlman,
  4. Michael Charlton and
  5. K. Sreekumaran Nair
  1. Division of Endocrinology and Metabolism, Mayo Clinic and Foundation, Rochester, Minnesota
    Diabetes 2001 Dec; 50(12): 2652-2658. https://doi.org/10.2337/diabetes.50.12.2652
    PreviousNext
    • Article
    • Figures & Tables
    • Info & Metrics
    • PDF
    Loading

    Article Figures & Tables

    Figures

    • Tables
    • FIG. 1.
      • Download figure
      • Open in new tab
      • Download powerpoint
      FIG. 1.

      FSR of mitochondrial (A) and sarcoplasmic/cytoplasmic (B) proteins in liver, heart, and skeletal muscle in control animals (saline), estimated using tissue fluid [13C]leucine enrichment as precursor pool. *Less than liver (P < 0.01); †less than heart (P < 0.01).

    • FIG. 2.
      • Download figure
      • Open in new tab
      • Download powerpoint
      FIG. 2.

      Skeletal muscle mitochondrial protein FSR. Synthesis rates were calculated using the three precursor pool enrichments shown. P values reflect comparisons (t test) between S and either Ins or Ins+AA. There were no significant differences between Ins and Ins+AA (P > 0.19).

    • FIG. 3.
      • Download figure
      • Open in new tab
      • Download powerpoint
      FIG. 3.

      Skeletal muscle sarcoplasmic protein FSR. Synthesis rates were calculated using the three precursor pool enrichments shown. P values reflect comparisons (t test) between S and either Ins or Ins+AA. There were no significant differences between Ins and Ins+AA (P > 0.29).

    • FIG. 4.
      • Download figure
      • Open in new tab
      • Download powerpoint
      FIG. 4.

      Skeletal muscle MHC protein FSR. Synthesis rates were calculated using the three precursor pool enrichments shown. P values reflect comparisons (t test) between S and either Ins or Ins+AA. There were no significant differences between Ins and Ins+AA (P > 0.42).

    • FIG. 5.
      • Download figure
      • Open in new tab
      • Download powerpoint
      FIG. 5.

      Heart mitochondrial protein FSR. Synthesis rates were calculated using the three precursor pool enrichments shown. P values reflect comparisons (t test) among groups.

    • FIG. 6.
      • Download figure
      • Open in new tab
      • Download powerpoint
      FIG. 6.

      Heart sarcoplasmic protein FSR. Synthesis rates were calculated using the three precursor pool enrichments shown. P values reflect comparisons (t test) among groups.

    • FIG. 7.
      • Download figure
      • Open in new tab
      • Download powerpoint
      FIG. 7.

      Liver mitochondrial protein FSR. Synthesis rates were calculated using the four available precursor pool enrichments shown. P values reflect comparisons (t test) between S and either Ins or Ins+AA. There were no significant differences between Ins and Ins+AA (P > 0.23).

    • FIG. 8.
      • Download figure
      • Open in new tab
      • Download powerpoint
      FIG. 8.

      Liver cytoplasmic protein FSR. Synthesis rates were calculated using the four available precursor pool enrichments shown. P values reflect comparisons (t test) between S and either Ins or Ins+AA. There were no significant differences between Ins and Ins+AA (P > 0.26).

    Tables

    • Figures
    • TABLE 1

      [13C]leucine enrichments in tissue fluid and bound in mitochondrial and sarcoplasmic proteins in each tissue

      TissueTissue fluid (mole % excess)Mitochondrial protein (atom % excess)Sarcoplasmic protein (atom % excess)
      Liver
       Saline4.95 ± 0.370.132 ± 0.0100.079 ± 0.015
       Insulin5.27 ± 0.360.102 ± 0.0140.091 ± 0.011
       INS+AA3.91 ± 0.26*†0.070 ± 0.007*0.054 ± 0.008†
      Heart
       Saline3.98 ± 0.280.081 ± 0.0040.085 ± 0.005
       Insulin4.50 ± 0.24*0.094 ± 0.003*0.105 ± 0.004*
       INS+AA2.88 ± 0.04†0.068 ± 0.003*†0.079 ± 0.004†
      Muscle
       Saline2.96 ± 0.170.020 ± 0.0030.011 ± 0.002
       Insulin2.63 ± 0.230.036 ± 0.005*0.017 ± 0.004
       INS+AA2.22 ± 0.10*0.025 ± 0.0030.010 ± 0.002
      • Data are means ± SE. Significant differences (P < 0.05) versus control (

      • *

        * ) and insuline (

      • †

        † ) groups. INS+AA, insulin in conjunction with amino acids.

    PreviousNext
    Back to top

    In this Issue

    December 2001, 50(12)
    • Table of Contents
    • Index by Author
    Sign up to receive current issue alerts
    View Selected Citations (0)
    Print
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for your interest in spreading the word about Diabetes.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Tissue-Specific Regulation of Mitochondrial and Cytoplasmic Protein Synthesis Rates by Insulin
    (Your Name) has forwarded a page to you from Diabetes
    (Your Name) thought you would like to see this page from the Diabetes web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Tissue-Specific Regulation of Mitochondrial and Cytoplasmic Protein Synthesis Rates by Insulin
    Yves Boirie, Kevin R. Short, Bo Ahlman, Michael Charlton, K. Sreekumaran Nair
    Diabetes Dec 2001, 50 (12) 2652-2658; DOI: 10.2337/diabetes.50.12.2652

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Add to Selected Citations
    Share

    Tissue-Specific Regulation of Mitochondrial and Cytoplasmic Protein Synthesis Rates by Insulin
    Yves Boirie, Kevin R. Short, Bo Ahlman, Michael Charlton, K. Sreekumaran Nair
    Diabetes Dec 2001, 50 (12) 2652-2658; DOI: 10.2337/diabetes.50.12.2652
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Abstract
      • RESEARCH DESIGN AND METHODS
      • RESULTS
      • DISCUSSION
      • Acknowledgments
      • Footnotes
      • REFERENCES
    • Figures & Tables
    • Info & Metrics
    • PDF

    Related Articles

    Cited By...

    More in this TOC Section

    • Insulin Resistance and Lipodystrophy in Mice Lacking Ribosomal S6 Kinase 2
    • Combined Infusion of Epinephrine and Norepinephrine During Moderate Exercise Reproduces the Glucoregulatory Response of Intense Exercise
    • Involvement of AMP-Activated Protein Kinase in Glucose Uptake Stimulated by the Globular Domain of Adiponectin in Primary Rat Adipocytes
    Show more Metabolism and Signal Transduction

    Similar Articles

    Navigate

    • Current Issue
    • Online Ahead of Print
    • Scientific Sessions Abstracts
    • Collections
    • Archives
    • Submit
    • Subscribe
    • Email Alerts
    • RSS Feeds

    More Information

    • About the Journal
    • Instructions for Authors
    • Journal Policies
    • Reprints and Permissions
    • Advertising
    • Privacy Policy: ADA Journals
    • Copyright Notice/Public Access Policy
    • Contact Us

    Other ADA Resources

    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • Scientific Sessions Abstracts
    • Standards of Medical Care in Diabetes
    • BMJ Open - Diabetes Research & Care
    • Professional Books
    • Diabetes Forecast

     

    • DiabetesJournals.org
    • Diabetes Core Update
    • ADA's DiabetesPro
    • ADA Member Directory
    • Diabetes.org

    © 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.